Qiagen managing body member Roland Sackers receives 8,075 shares in stock-unit settlement
QGEN•Roland Sackers received 8,075 Qiagen common shares on Oct. 31, 2026, through net settlement of performance stock units. The transaction value was not quantifiable.
1. Share settlement
The settlement covered 15,349 performance stock units granted on Oct. 31, 2016, with a $0 exercise price. Shares were withheld to cover related expenses; Qiagen’s closing share price on Oct. 30, 2026, was $50.22. Sackers also received 22,895 shares previously pledged in a securities lending transaction. The transaction was classified as “Another,” linked to share option programs, rather than a purchase or sale.
